Pneumonia News and Research

Latest Pneumonia News and Research

Two-step regimen of experimental MERS vaccines show promise in mice

Two-step regimen of experimental MERS vaccines show promise in mice

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Less invasive endovascular aortic repair benefits most patients, provides quick recovery

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Amgen announces submission of supplemental New Drug Application to FDA for Kyprolis (carfilzomib)

Southampton scientists set to analyse investments into infectious disease research

Southampton scientists set to analyse investments into infectious disease research

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

Retail meat harbors disease-causing Klebsiella pneumoniae, shows new study

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

C2N-8E12 (ABBV-8E12) gets orphan drug designation from FDA for PSP treatment

UK investment lacking for pneumonia research

UK investment lacking for pneumonia research

Scientists discover new variant of streptococcal bacteria that contributes to severe infections

Scientists discover new variant of streptococcal bacteria that contributes to severe infections

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

New study highlights burden of community-acquired pneumonia hospitalizations among U.S. adults

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

IMBRUVICA (ibrutinib) approved in Europe for treatment of Waldenstrom's macroglobulinemia

Janssen-sponsored Phase 2b trial shows guselkumab effective in treating moderate to severe plaque psoriasis

Janssen-sponsored Phase 2b trial shows guselkumab effective in treating moderate to severe plaque psoriasis

Surgery delays for elderly patients with traumatic spinal cord injury

Surgery delays for elderly patients with traumatic spinal cord injury

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Sepsis readmissions have significant impact on health care expenditures in California

Sepsis readmissions have significant impact on health care expenditures in California

Older patients with traumatic spinal cord injury less likely to get surgical treatment compared with younger patients

Older patients with traumatic spinal cord injury less likely to get surgical treatment compared with younger patients

Researchers awarded grant from British Council to reduce burden of infectious disease in Malaysia

Researchers awarded grant from British Council to reduce burden of infectious disease in Malaysia

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

UTHealth School of Public Health working to improve health of Hispanics living along Texas-Mexico border

Mortality rates vary depending on socioeconomic differences among areas in Europe

Mortality rates vary depending on socioeconomic differences among areas in Europe

Dr. Jian-Dong Li receives $1.6 million to develop novel therapeutic targets to treat middle-ear infections

Dr. Jian-Dong Li receives $1.6 million to develop novel therapeutic targets to treat middle-ear infections

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.